News Medivation in merger talks with Sanofi and others Sources say Pfizer and Celgene are also interested.
R&D BMS looks for cancer combos with Cormorant buy Bristol searching for new immuno-oncology combinations.
UK & Europe Amgen's Kyprolis gains expanded myeloma use in Europe Kyprolis gains label expansion in Europe
US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
News Novartis buys into bispecific antibodies with Xencor deal Agreement could add to Novartis' immuno-oncology pipeline.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
